AI-generated summary
The authors report a secondary analysis of a small double-blind, sham-controlled trial in patients with moderate traumatic brain injury, using MR spectroscopy to track the mIns/NAA ratio in the corpus callosum over time. Sham-treated participants showed a rise in mIns/NAA from the acute to late subacute phase, while the LLLT group remained relatively stable, a difference the authors describe as a possible neuroprotective and anti-inflammatory effect. They note the sample size was small.
- Participants
- 34
- Who or what was studied
- Patients with moderate traumatic brain injury (34 participants in the final data set, 18 men, age 49 ± 17, range 20-79; 15 LLLT, 19 sham)
- Limits stated in the abstract
- The authors state that the sample size was small, and the findings are a secondary analysis of a single-site study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ajnr.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Traumatic brain injury, Sham, Brain injury, Placebo-controlled, Neuroinflammation, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.